YKTS (YKTS) Fair Value & Analysis
· Market cap €40.1M
Fair value as of: Jul 1, 2026
From 22 valuation models · updated yesterday
Share price +4.0% over the past month.
Price vs Fair Value (12 months)
12‑month range €17.70 – €21.00 · fair‑value band €5.52 – €7.31 · the €21.00 price screens above the €7.31 fair value. As of Jul 1, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
YKTS (YKTS) currently trades at €21.00, while our model-based Fair Value estimate is €7.31 — implying the stock looks roughly 65.2% overvalued today. We read business quality at 57/100 (solid quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Net debt stands at €10.1M. The stock trades on a trailing P/E of 112.2. Fundamentals as of Jul 1, 2026
Key figures & financial health
Figures from reported company fundamentals (EODHD) · as of Jul 1, 2026. TTM = trailing twelve months.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
YKTS reported revenue of €3.5M in FY2025 versus €514K in FY2021, a compound +62.0%/yr. Reported net income was €333K in FY2025.
Is YKTS fairly valued? → Check now
Explore undervalued stocks
Frequently asked questions
Is YKTS (YKTS) undervalued?
What is the fair value of YKTS?
What is the quality score of YKTS?
What is the net profit margin of YKTS?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.